WFUMB safety symposium on echo-contrast agents: Nature and types of ultrasound contrast agents

Ultrasound in Medicine and Biology

Volumn 33, Issue 2, 2007, Pages 187-196

  Bouakaz, Ayache ^a   de Jong, Nico ^b  

^a INSERM   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; ECHO CONTRAST MEDIUM; ECHOVIST; NC 100100; PERFLEXANE; PERFLUTREN; QUANTISON; SONOVUE;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HYDROSTATIC PRESSURE; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; LIGHT SCATTERING; MATHEMATICAL ANALYSIS; MICROBUBBLE; PRIORITY JOURNAL; SAFETY; SIMULATION; TEMPERATURE DEPENDENCE; ULTRASOUND;

EQUIPMENT DESIGN; HUMANS; INJECTIONS; MICROBUBBLES; PRESSURE; SAFETY; TEMPERATURE; TIME FACTORS; ULTRASONICS; ULTRASONOGRAPHY; VIBRATION;

EID: 33846900264     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2006.07.008     Document Type: Article

References (26)

1. Barnhart J., Levene H., Villapando E., et al. Characteristics of Albunex®: air-filled albumin microspheres for echocardiography contrast enhancement. Invest Radiol 25 Suppl. 1 (1990) S162-S164
2. Bouakaz A., Versluis M., and de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol 31 (2005) 391-399
3. Bouakaz A., Frinking P.J., de Jong N., and Bom N. Noninvasive measurement of the hydrostatic pressure in a fluid-filled cavity based on the disappearance time of micrometer-sized free gas bubbles. Ultrasound Med Biol 25 (1999) 1407-1415
4. Bouakaz A., de Jong N., Cachard C., and Jouini K. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent. Ultrasonics 36 (1998) 703-708
5. de Jong N., Hoff L., Skotland T., and Bom N. Absorption and scatter of encapsulated gas filled microspheres: Theoretical considerations and some measurements. Ultrasonics 30 (1992) 95-103
6. de Jong N., Ten Cate F.J., Lancee C.T., Roelandt J.R., and Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 29 (1991) 324-330
7. Fisher N.G., Leong-Poi H., Sakuma T., et al. Detection of coronary stenosis and myocardial viability using a singe iv bolus injection of BR14®. J Am Coll Cardiol 39 (2002) 523-529
8. Frinking J., and de Jong N. Acoustic modeling of shell-encapsulated gas bubbles. Ultrasound Med Biol 24 (1998) 523-533
9. Goldberg B.B., Liu J.B., and Forsberg F. Ultrasound contrast agents: A review. Ultrasound Med Biol 20 (1994) 319-333
10. Gorce J., Arditi M., and Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents. Invest Radiol 35 (2000) 661-671
11. Gramiak R., and Shah P. Echocardiography of the aortic root. Invest Radiol 3 (1968) 356-366
12. Hogg J.C. Neutrophil kinetics and lung injury. Physiological Review 67 (1987) 1249-1295
13. Hoff L, Sontum PC, Hovem JM. Acoustic characterisation of Nycomeds NC100100 contrast agent. Presented at IEEE Ultrasonics Symposium, Sendai, Japan, 1998.
14. Kabalnov A., Klein D., Pelura T., Schutt E., and Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. Ultrasound Med Biol 24 (1998) 739-749
15. Lindner J., Dayton P., and Coggins M. Noninvasive imaging of inflammation by us detection of phagocytosed microbubbles. Circulation 102 (2000) 531-538
16. Meltzer R.S., Serruys P.W., McGhie J., and Roelandt J. Pulmonary wedge injection yielding left sided echocardiographic contrast. Br Heart J 44 (1980) 390-394
17. Ophir J., and Parker K.J. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15 (1989) 319-333
18. Porter E.A. Effect of blood and microbubble oxygen and nitrogen content on perfluorocarbon-filled dextrose albumin microbubble size and efficacy. J Am Soc Echocardiogr 11 (1995) 421-425
19. Porter T.R., and Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. Circulation 92 (1995) 2391-2395
20. Schlief R. Ultrasound contrast agents. Curr Opin Radiol 3 (1991) 198-207
21. Schlief R., and Mahler M. Successful opacification of left heart chambers on echocardiographic examination after iv injection of a new saccharide based contrast agent. Echocardiography 7 (1990) 61-64
22. Schneider M., Arditi M., Barrau B., et al. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 30 (1995) 451-457
23. Shapiro J.S., Reisner S.A., Lichtenberg G.S., and Meltzer R.S. Intravenous contrast echocardiography with use of sonicated albumin in humans: Systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol 7 (1990) 603-1607
24. Van Liew H.D., and Burkard M.E. Bubbles in circulating blood: Stabilization and simulations of cyclic changes of size and content. J Appl Physiol 79 (1995) 1379-1385
25. Van Liew H.D., and Burkard M.E. Relationship of oxygen content to PO2 for stabilized bubbles in the circulation: Theory. J Appl Physiol 81 (1996) 500-508
26. Walovitch R., Kwan O., and Picard M. Initial safety and myocardial perfusion imaging results with AI-700®: A synthetic polymeric UCA. J Am Soc Echocardiogr 13 (2000) 457